EX-99.3 4 ex99_3biontech-overviewv.htm EX-99.3 ex99_3biontech-overviewv
Voting results - Overview BioNTech SE, Mainz Ordinary Annual General Meeting on 25/05/2023 Page 1Note: Percentages rounded to 2 decimal places Item 2 Resolution on the Appropriation of Balance Sheet Profit for the 2021 Financial Year (adopted) 232,713,555 Shares for which valid votes were cast (= 93.63 % of capital stock) 232,692,836 Yes votes (99.99 %) 20,719 No votes (0.01 %) Item 3 Resolution on the Appropriation of Balance Sheet Profit for the 2022 Financial Year (adopted) 232,713,524 Shares for which valid votes were cast (= 93.63 % of capital stock) 232,692,263 Yes votes (99.99 %) 21,261 No votes (0.01 %) Item 4 Resolution on the Approval of the Actions of the Management Board (adopted) 192,986,218 Shares for which valid votes were cast (= 77.64 % of capital stock) 192,855,051 Yes votes (99.93 %) 131,167 No votes (0.07 %) Item 5 Resolution on the Approval of the Actions of the Supervisory Board (adopted) 229,573,321 Shares for which valid votes were cast (= 92.36 % of capital stock) 228,915,149 Yes votes (99.71 %) 658,172 No votes (0.29 %) Item 6 Resolution on the Appointment of the Auditor of the Annual Financial Statements and the Auditor of the Consolidated Financial Statements for the 2023 Financial Year as well as the Auditor for any Audit or Review of Interim Financial Information During the Year (adopted) 232,635,368 Shares for which valid votes were cast (= 93.60 % of capital stock) 231,934,876 Yes votes (99.70 %) 700,492 No votes (0.30 %) Item 7 Resolution on the Approval of the Remuneration Report (adopted) 232,450,514 Shares for which valid votes were cast (= 93.52 % of capital stock) 222,787,864 Yes votes (95.84 %) 9,662,650 No votes (4.16 %) Item 8.1 Resolution on Elections to the Supervisory Board – Baroness Nicola Blackwood (adopted) 232,714,773 Shares for which valid votes were cast (= 93.63 % of capital stock) 231,694,409 Yes votes (99.56 %) 1,020,364 No votes (0.44 %) Item 8.2 Resolution on Elections to the Supervisory Board – Dr. Ulrich Wandschneider (adopted) 232,717,665 Shares for which valid votes were cast (= 93.63 % of capital stock) 231,707,511 Yes votes (99.57 %) 1,010,154 No votes (0.43 %) Item 8.3 Resolution on Elections to the Supervisory Board – Michael Motschmann (adopted) 232,715,704 Shares for which valid votes were cast (= 93.63 % of capital stock) 227,783,769 Yes votes (97.88 %) 4,931,935 No votes (2.12 %)


 
Voting results - Overview BioNTech SE, Mainz Ordinary Annual General Meeting on 25/05/2023 Page 2Note: Percentages rounded to 2 decimal places Item 9 Resolution on the Amendment to Sec. 16 para. 5 of the Articles of Association to Authorize the Management Board to Provide for the Holding of a Virtual Annual General Meeting (adopted) 232,721,487 Shares for which valid votes were cast (= 93.63 % of capital stock) 228,762,725 Yes votes (98.30 %) 3,958,762 No votes (1.70 %) Item 10 Resolution on the Amendment to Sec. 16 para. 4 of the Articles of Association concerning the Participation of Supervisory Board Members in the Annual General Meeting by means of Video and Audio Transmission (adopted) 232,194,565 Shares for which valid votes were cast (= 93.42 % of capital stock) 228,992,375 Yes votes (98.62 %) 3,202,190 No votes (1.38 %) Item 11.1 Resolution on the Approval of the Conclusion of Four Domination and Profit and Loss Transfer Agreements - BioNTech Idar-Oberstein Services GmbH (adopted) 232,700,341 Shares for which valid votes were cast (= 93.62 % of capital stock) 232,680,446 Yes votes (99.99 %) 19,895 No votes (0.01 %) Item 11.2 Resolution on the Approval of the Conclusion of Four Domination and Profit and Loss Transfer Agreements - NT Security and Services GmbH (adopted) 232,698,467 Shares for which valid votes were cast (= 93.62 % of capital stock) 232,677,938 Yes votes (99.99 %) 20,529 No votes (0.01 %) Item 11.3 Resolution on the Approval of the Conclusion of Four Domination and Profit and Loss Transfer Agreements - BioNTech BioNTainer Holding GmbH (adopted) 232,701,041 Shares for which valid votes were cast (= 93.62 % of capital stock) 232,681,127 Yes votes (99.99 %) 19,914 No votes (0.01 %) Item 11.4 Resolution on the Approval of the Conclusion of Four Domination and Profit and Loss Transfer Agreements - BioNTech Individualized mRNA Manufacturing GmbH (adopted) 232,686,790 Shares for which valid votes were cast (= 93.62 % of capital stock) 232,667,715 Yes votes (99.99 %) 19,075 No votes (0.01 %)